Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Analysis 6.9. Comparison 6 Artesunate plus mefloquine vs Artemether-lumefantrine, Outcome 9 Early<br />
vomiting.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 6 Artesunate plus mefloquine vs Artemether-lumefantrine<br />
Outcome: 9 Early vomiting<br />
Study or subgroup AS+MQ AL6 Risk Ratio Risk Ratio<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Van Vugt 1998 THA 5/50 4/150 3.75 [ 1.05, 13.42 ]<br />
Lefevre 1999 THA 1/55 2/164 1.49 [ 0.14, 16.12 ]<br />
Hutagalung 2002 THA 2/245 5/245 0.40 [ 0.08, 2.04 ]<br />
Mayxay 2003 LAO 3/110 6/110 0.50 [ 0.13, 1.95 ]<br />
Stohrer 2003 LAO 0/55 0/53 0.0 [ 0.0, 0.0 ]<br />
Van den Broek 2003a BGD 1/121 0/121 3.00 [ 0.12, 72.92 ]<br />
Total (95% CI) 636 843 1.07 [ 0.55, 2.08 ]<br />
Total events: 12 (AS+MQ), 17 (AL6)<br />
Heterogeneity: Chi 2 = 6.79, df = 4 (P = 0.15); I 2 =41%<br />
Test <strong>for</strong> overall effect: Z = 0.19 (P = 0.85)<br />
0.01 0.1 1 10 100<br />
Favours ASMQ Favours AL<br />
Analysis 7.1. Comparison 7 Artesunate plus mefloquine vs Artesunate plus amodiaquine, Outcome 1 Total<br />
Failure (P. falciparum) Day 28 PCR unadjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 7 Artesunate plus mefloquine vs Artesunate plus amodiaquine<br />
Outcome: 1 Total Failure (P. falciparum) Day 28 PCR unadjusted<br />
Study or subgroup AS+MQ AS+AQ Risk Ratio Weight Risk Ratio<br />
1 Africa<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Faye 2003 SEN 2/144 9/349 100.0 % 0.54 [ 0.12, 2.46 ]<br />
0.01 0.1 1 10 100<br />
Favours AS+MQ Favours AS+AQ<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
162